Connect
MJA
MJA

Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time

Annette K Regan, Christopher C Blyth and Paul V Effler
Med J Aust 2013; 199 (11): 744-746. || doi: 10.5694/mja13.10712
Published online: 16 December 2013

To the Editor: Despite evidence supporting the safety and benefits of influenza vaccination during pregnancy,1,2 half of pregnant women believe the influenza vaccine to be unsafe or are uncertain about its safety in pregnancy.3 Other studies report confusion among antenatal care providers about the safety of influenza vaccination during pregnancy, and cite the need for more professional education.4

  • Annette K Regan1
  • Christopher C Blyth1
  • Paul V Effler2

  • 1 University of Western Australia, Perth, WA.
  • 2 Department of Health, Western Australia, Perth, WA.


Acknowledgements: 

We thank Hayley Roberts, Caroline Talbot and other Vaccine Trials Group staff for their help with collecting data.

Competing interests:

Christopher Blyth is a member of the Vaccine Trials Group, which has received funding from vaccine providers, including Sanofi Pasteur, BioCSL and GlaxoSmithKline.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.